PRODUCT INFORMATION

 I.TECHNICAL SPECIFICATIONS

Structural / Composition Data

Structure / Formula

 Polydeoxyribonucleotide; linear polymer of 2'-deoxyribonucleotides (50-1500 base pairs)

Molecular Weight

~50 - 1,500 kDa (Mixture of fragments)
 PDRN can be categorized into three molecular weight fractions:

Appearance

 Liquid

Concentration

  15% 

Solubility

 Soluble in aqueous buffers (e.g., saline, sterile water)

Form(s) Available

 Sterile injection

Stability & Shelf Life

Storage

 24 months at 2–8 °C (protected from light); 36 months at –20 °C

Post-Reconstitution

 Use immediately or store at 2–8 °C for up to 24 hours.

Stability Notes

 Protect from light. Avoid repeated freeze-thaw cycles. Use sterile techniques.

Quality & Compliance

QC Tests

 Confirmed

Media

 Buffer PBS

Documentation

 Available upon request.

 II. PREPARATION / RECONSTITUTION

General Guidance

 Reconstitute with 100mL Sterile PBS for injection to achieve the desired concentration (e.g., 5-10 mg/mL). 

Recommendations

 For injectable use, reconstitute immediately prior to use. Filter through a 0.22µm filter if necessary.

 III. MECHANISM & BIOLOGICAL FUNCTION

Mechanism of Action

 Binds to and activates the Adenosine A2A Receptor (A2AR). Acts as a "building block" and signaling molecule, promoting tissue repair and modulating inflammation. Promotes angiogenesis via VEGF upregulation. 

Biological Claims

 • Tissue Regeneration & Wound Healing
 • Powerful Anti-Inflammatory Action
 • Stimulation of Angiogenesis (new blood vessel formation)
 • Collagen Synthesis & Fibroblast Proliferation

 IV. APPLICATIONS

Intended Uses

 For research purpose only

 V. PACKAGING & PRESENTATION

Sizes per vial 

50000 PPM / vials